Main Session
Sep
29
SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy
315 - Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy
Presenter(s)
Krishnan Patel, MD - The University of Texas MD Anderson Cancer Center, Houston, TX